ANVS

Conviction 13HealthcareScan · Fri, Jun 26, 2026

Bullish harami

ANVS$1.70+3.03%

ResistanceSupportVol 14Insider buy

Vol MA14 956.72K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Annovis Bio, Inc.PHARMACEUTICAL PREPARATIONSwww.annovisbio.com ↗

Price1.70

Change+3.03%

Gap+0.61%

Rel volume1.44×

Avg volume1.09M

Avg $ vol1.96M

SMA 201.79

SMA 501.94

SMA 2002.55

Price vs 50-12.52%

Price vs 200-33.38%

MA stackbearish

50/200 cross—

Supertrenddown · 2.02

RSI (14)40

MACD hist-0.00

MACD cross—

Stoch %K / %D18 / 7

ADX (14)8

+DI / −DI17 / 20

RSI divergence—

MACD divergence—

ATR %+7.39%

ADR %6.44%

52w high5.10

52w low1.59

From 52w high-66.67%

Above 52w low+6.92%

New 52w highNo

SqueezeOn · 4d

Bollinger width17.73%

%B0.21

Donchian pos13.10%

Donchian high2.07

Donchian low1.65

AVWAP (52w high)2.47

vs AVWAP high-31.13%

AVWAP (52w low)1.92

vs AVWAP low-11.58%

OBV trendFlat

Chaikin MF (20)-0.31

Today vs 20d1.44×

Avg vol (14d)956.72K

Avg vol (20d)1.09M

Avg $ vol (20d)1.96M

Market cap—

RS 3m (vs SPY)-37.47%

RS 6m (vs SPY)-65.24%

RS line new highNo

Trend template1/8

Technical rank11.0

1 week-2.86%

1 month-15.42%

3 months-20.93%

6 months-52.51%

1 year-25.76%

YTD-53.42%

P/E-1.99

P/B18.34

P/S—

P/FCF—

EPS-1.40

Div yield—

ROE-923.02%

ROA-177.63%

Debt/Eq—

Current0.61

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-17.34%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value43.12M

Revenue0

Net income-17.61M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNYSE

Shares out34.65M

Employees7

ListedWed, Jan 29, 2020

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction13 / 100

Pattern quality—

Tech rank11.0 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish harami

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ANVS

All disclosures →

No recent disclosed trades by Congress in ANVS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ANVS · 3 buys

Insider	Side	Shares	Value	Traded	Filed
Hoffman Michael B Director · Common Stock · 2026-05-20	Buy	54.93K	$104K	2026-05-20	2026-05-21
Hoffman Michael B Director · Common Stock · 2026-05-20	Buy	2.56K	$4K	2026-05-20	2026-05-21
Hoffman Michael B Director · Common Stock · 2026-05-20	Other	—	—	2026-05-20	2026-05-21
Hoffman Michael B Director · Common Stock · 2026-05-20	Buy	18.85K	$34K	2026-05-20	2026-05-21

SEC filings

EDGAR filings in ANVS · 1 recent

EDGAR →

8-K8-KWed, Jun 17, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.